Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Ibuprofen is a nonsteroidal anti-inflammatory drug (NSAID) widely used to relieve pain, reduce fever, and decrease inflammation. It acts as a non-selective inhibitor of cyclooxygenase (COX), blocking both COX‑1 and COX‑2 enzymes, which are involved in the synthesis of prostaglandins and thromboxanes from arachidonic acid. By reducing prostaglandin production, ibuprofen alleviates symptoms such as pain, swelling, stiffness, and fever. It is indicated for mild to moderate pain (including headache, toothache, back pain), dysmenorrhea (menstrual cramps), arthritis (osteoarthritis and rheumatoid arthritis), musculoskeletal disorders, migraines, minor injuries, and fever reduction in adults and children over 6 months old. Ibuprofen can be administered orally or intravenously[1][2][3][4][5].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on ibuprofen.